Top 40 Companies in Global Antimicrobial Susceptibility Testing Market Global Share, Market Size, Revenue Report (2024–2035)

According to a Research Report Published by Spherical Insights & Consulting, The Global Antimicrobial Susceptibility Testing Market Size is projected to Grow from USD 4.43 Billion in 2024 to USD 8.34 Billion by 2035, at a CAGR of 5.92% during the forecast period 2024–2035. The Antimicrobial Susceptibility Testing Market is driven by rising antimicrobial resistance, increasing infectious disease burden, demand for rapid diagnostic solutions, technological advancements in testing methods, and supportive government initiatives promoting effective antibiotic stewardship and infection control programs worldwide.

 

Introduction

The Global Antimicrobial Susceptibility Testing (AST) Market refers to diagnostic techniques used to determine the effectiveness of antimicrobial agents against pathogens, helping guide appropriate treatment decisions. The market depends on fundamental materials which include culture media and reagents and antibiotic discs and testing kits that laboratories need to conduct their operations. AST is widely used in clinical diagnostics, pharmaceutical research, epidemiological studies, and drug development to combat infectious diseases and monitor resistance patterns. The main market trends at present show that testing systems which use artificial intelligence and fast automated testing systems and sophisticated molecular diagnostic systems have improved their testing results. The market will experience major development through rising demand for quick diagnostic tests and personalized medicine solutions. The worldwide market expansion receives support from government programs and global health organizations which establish antimicrobial resistance (AMR) surveillance systems and finance scientific investigations and promote safe antibiotic practices.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Antimicrobial Susceptibility Testing Market.

 

Global Antimicrobial Susceptibility Testing Market Size, Share, By Product (Manual AST, and More), By Testing Type (Antibacterial, Antifungal, and More), By Application (Clinical Diagnostics, and More), By End User (Hospital Laboratories, Reference Laboratories, and More), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2024 - 2035

 

Antimicrobial Susceptibility Testing Market Size & Statistics

• The Market Size for Antimicrobial Susceptibility Testing Was estimated to be worth USD 4.43 Billion in 2024.
• The Market is going to Expand at a CAGR of 5.92% between 2024 and 2035.
• The Antimicrobial Susceptibility Testing Market Size is anticipated to Reach USD 8.34 Billion by 2035.
• North America is expected to generate the highest demand during the forecast period in the Antimicrobial Susceptibility Testing Market
• Asia Pacific is expected to grow the fastest during the forecast period in the Antimicrobial Susceptibility Testing Market.

Regional growth and demand                                      

Asia Pacific is expected to grow the fastest during the forecast period in the Antimicrobial Susceptibility Testing market. Asia Pacific is expected to grow fastest due to rising infectious disease cases, increasing antimicrobial resistance, expanding healthcare infrastructure, growing diagnostic laboratories, and strong government initiatives supporting advanced diagnostic technologies and surveillance programs across emerging economies such as China and India.

 

North America is expected to generate the highest demand during the forecast period in the Antimicrobial Susceptibility Testing market. North America is expected to generate the highest demand due to advanced healthcare infrastructure, strong presence of key market players, high adoption of automated diagnostic technologies, rising antimicrobial resistance awareness, and significant government funding for infection control and research programs.

 

Top 10 Trends in the Antimicrobial Susceptibility Testing Market

• Automated testing systems
• Rapid diagnostic solutions
• AI & machine learning integration
• Point-of-care testing growth
• Molecular testing adoption
• Digital microbiology platforms
• Multiplex testing demand
• AMR surveillance expansion
• Combination therapy testing
• Cloud-based lab connectivity

 

1. Automated testing systems
   Automated antimicrobial susceptibility testing systems are gaining traction due to their ability to deliver faster, standardized, and high-throughput results, reducing human error and improving laboratory efficiency in clinical diagnostics.
   
    
2. Rapid diagnostic solutions
   Rapid diagnostic technologies are increasingly adopted as they significantly reduce turnaround time, enabling quicker clinical decision-making, early infection control, and timely initiation of appropriate antimicrobial therapy for better patient outcomes.
   
    
3. AI & machine learning integration
   Artificial intelligence and machine learning are transforming AST by enhancing data analysis, predicting resistance patterns, and supporting clinicians with accurate treatment decisions, leading to improved diagnostic precision and optimized antimicrobial use.
   
    
4. Point-of-care testing growth
   Point-of-care testing is expanding due to the need for decentralized diagnostics, especially in remote and resource-limited settings, allowing immediate results and faster treatment decisions without reliance on centralized laboratories.
   
    
5. Molecular testing adoption
   Molecular diagnostic methods such as PCR and genomic sequencing are increasingly used for AST as they provide precise, sensitive, and rapid detection of pathogens and resistance genes, supporting advanced and personalized treatment approaches.

 

     Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Antimicrobial Susceptibility Testing market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Antimicrobial Susceptibility Testing Market.

 

Top 40 Companies Leading the Antimicrobial Susceptibility Testing Market

1. bioMerieux
2. Becton, Dickinson and Company
3. Thermo Fisher Scientific
4. Bio-Rad Laboratories
5. Danaher Corporation
6. Bruker Corporation
7. Roche Diagnostics
8. Abbott Laboratories
9. Merck KGaA
10. Agilent Technologies
11. QIAGEN N.V.
12. HiMedia Laboratories
13. Accelerate Diagnostics
14. Alifax S.r.l.
15. Liofilchem S.r.l.
16. Creative Diagnostics
17. ELITechGroup
18. Cepheid
19. Mast Group Ltd.
20. Synbiosis
21. T2 Biosystems
22. Resistell AG
23. Seegene Inc.
24. Luminex Corporation
25. Nissui Pharmaceutical
26. Zhuhai DL Biotech
27. Genefluidics Inc.
28. BacterioScan Inc.
29. NuMedii Inc.
30. Microbiologics Inc.
31. Eurofins Scientific
32. IDEXX Laboratories
33. Neogen Corporation
34. R-Biopharm AG
35. Hardy Diagnostics
36. Condalab
37. FASTinov SA
38. SSI Diagnostica
39. Biogal Galed Labs
40. Virbac

 

1. BioMerieux
   Headquarters: Marcy-etoile, France
   BioMerieux reported estimated 2025 revenue of around USD 4.5 billion. The company specializes in in vitro diagnostics, particularly microbiology and antimicrobial susceptibility testing solutions. It offers automated systems like VITEK, widely used in clinical labs. With strong global presence and continuous innovation, bioMérieux plays a key role in combating antimicrobial resistance through advanced diagnostic technologies.
   
    
2. Becton, Dickinson and Company (BD)
   Headquarters: Franklin Lakes, USA
   Becton, Dickinson and Company reported estimated 2025 revenue exceeding USD 21 billion. BD is a global medical technology company offering advanced diagnostic systems, including automated AST platforms. Its BD Phoenix system enhances laboratory efficiency and accuracy. The company’s strong R&D, global distribution network, and focus on infection prevention strengthen its leadership in antimicrobial diagnostics
   
    
3. Thermo Fisher Scientific
   Headquarters: Waltham, USA
   Thermo Fisher Scientific reported estimated 2025 revenue of about USD 45 billion. The company provides a wide range of laboratory products, including AST solutions, culture media, and molecular diagnostics. Its innovative technologies support clinical and research applications. With extensive global reach and continuous investment in life sciences, Thermo Fisher plays a crucial role in infectious disease diagnostics.
   
    
4. Bio-Rad Laboratories
   Headquarters: Hercules, USA
   Bio-Rad Laboratories reported estimated 2025 revenue of around USD 3 billion. The company develops diagnostic systems and quality controls used in microbiology and AST testing. It focuses on precision, reliability, and innovation. Bio-Rad’s strong presence in clinical diagnostics and life science research supports laboratories in delivering accurate antimicrobial resistance testing worldwide.
   
    
5. Danaher Corporation
   Headquarters: Washington, D.C., USA
   Danaher Corporation reported estimated 2025 revenue of approximately USD 32 billion. Through subsidiaries like Beckman Coulter, Danaher provides advanced diagnostic tools including microbiology and AST solutions. The company emphasizes innovation, automation, and efficiency. Its diversified portfolio, strong R&D capabilities, and global footprint make it a major contributor to antimicrobial susceptibility testing advancements.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Antimicrobial Susceptibility Testing Market.

 

Are you ready to discover more about the Antimicrobial Susceptibility Testing market?

The report provides an in-depth analysis of the leading companies operating in the Antimicrobial Susceptibility Testing market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profile

1. bioMerieux

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

1. Becton, Dickinson and Company
2. Thermo Fisher Scientific
3. Bio-Rad Laboratories
4. Danaher Corporation
5. Bruker Corporation
6. Roche Diagnostics
7. Abbott Laboratories
8. Merck KGaA
9. Others.

 

Conclusion

The global antimicrobial susceptibility testing market is poised for steady growth, driven by the increasing prevalence of antimicrobial resistance and rising demand for accurate and rapid diagnostic solutions. Technological advancements, including automation, artificial intelligence, and molecular diagnostics, are significantly enhancing testing efficiency and precision. Strong government initiatives and global surveillance programs further support market expansion. North America leads in demand due to advanced infrastructure, while Asia Pacific shows the fastest growth owing to expanding healthcare capabilities. The presence of key industry players and continuous innovation will remain critical in shaping the competitive landscape and addressing global infectious disease challenges effectively.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.  Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter